Clinical Trial Update: A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This update describes a Phase II clinical trial using organoid drug sensitivity testing to guide therapy in patients with unresectable hepatocellular carcinoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Unresectable Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING